This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Union Hospital Tongji Medical College Hust. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Weihua Qiao and a Regenerative Heart Valve Composite.
Introduction
Weihua Qiao is an inventor based in Wuhan, China, whose work includes a patent application concerning a decellularized heart valve composite. He is associated with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Latest Patents
Qiao’s listed patent is titled “Decellularized Heart Valve (DHV) Composite, and Preparation Method and Use Thereof.” The disclosure describes modifying a decellularized heart valve with a copper chloride–dopamine hydrochloride solution, then treating it with a GDF11 solution to produce the composite. It also describes using the composite to prepare a tissue-engineered heart valve designed to support remodeling and regeneration. The supplied information lists 1 patent.
Career Highlights
The patent focuses on combining material modification with GDF11 treatment to develop a heart valve construct with potential tissue-engineering applications. Qiao’s listed institutional affiliation connects this work with research at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Collaborations
The supplied information identifies Nianguo Dong and Ying Zhou as Qiao’s coworkers. Their names are provided as collaborators, though specific roles in the patent are not stated.
Conclusion
Weihua Qiao’s listed patent explores a decellularized heart valve composite intended for tissue-engineered valves with remodeling and regeneration capabilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile